Login

BVZ Holding CEO Fernando Lehner on H1 2022, Future Projects, and Motivating His Team Amidst Challenges | Fernando Lehner - CEO of bvz holding ag 00:10:00

Share On Facebook Share On Twitter

Fernando Lehner is the CEO of bvz holding ag

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Integrating ESOPs into Your Retirement Plan: Insights with Scott Sturgeon | Scott Sturgeon, Founder, Oread Wealth Partners.
00:10:00
focuses on making life simpler and more affordable for our generation|Ankur Jain,Co-CEO,Kairos HQ
00:10:00
Exploring Rewilding and Sustainable Investment Opportunities with Ben Goldsmith, CEO of Menhaden Capital, on the Money Maze Podcast
00:10:00
Christian Stendevad , CEO of Penneo outlines the company's European growth strategy, emphasizing digital solutions for client processes and KYC compliance.
00:10:00
SolarWinds CEO Sudhakar Ramakrishna focuses on enhancing productivity through AI initiatives.
00:10:00
Our Approach to Lifestyle Financial Planning with First Harrison Financial Services
00:10:00
Awale Resources Highlights Exploration Progress at One-to-One Conference
00:10:00
Over 60 Thousand Dreams of Home Ownership Fulfilled | Fabio Cury - CEO of Cury Construtora e Incorporadora SA
00:10:00
A More Involved Way To Do Capital|Senofer Mendoza,Founder and General Partner,Mendoza Ventures
00:10:00
Barnes Group: Crafting Connecticut's Success | Thomas J. Hook - President & Chief Executive Officer of Barnes
00:10:00
The invariant subspace method was applied to the study of continuous-time quantum walk (CTQW)|Chen-Fu Chiang,Quantum technologies
00:10:00
Perion Network CEO Tal Jacobson joins Nicole Petallides to discuss the company's role in major digital advertising channels.

© 2017 - Neuhu+